Brief: Tetra Bio-Pharma Provides Update On Clinical Development Program For Qixleef

Tetra Bio Pharma

14/10/2021 11:43

Oct 14 (Reuters) - Tetra Bio Pharma Inc  TBP.TO :
    * TETRA BIO-PHARMA PROVIDES UPDATE ON CLINICAL DEVELOPMENT
PROGRAM
FOR QIXLEEF™
    * TETRA BIO PHARMA INC - FINALIZING ITS RAW MATERIAL GLOBAL
SUPPLY
PLANS
    * TETRA BIO PHARMA - IN PARTNERING DISCUSSIONS AS IT
PREPARES TO
INITIATE LAST STAGE OF DRUG DEVELOPMENT OF QIXLEEF FOR
INDICATION IN BREAKTHROUGH PAIN
    * TETRA BIO PHARMA - WILL LEVERAGE LONG-TERM SAFETY DATA
GATHERED
IN PLENITUDE TRIAL TO SUPPLEMENT SAFETY AND EFFICACY DATA FOR
REBORN TRIALS

Source text for Eikon:  ID:nPn3h5PwLa 
Further company coverage:  TBP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))